Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Supplementary figure S1 from Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • الموضوع:
      2024
    • نبذة مختصرة :
      The study design illustrated here shows the treatment phase with combination paclitaxel and pembrolizumab, followed by maintenance pembrolizumab if disease is stable or improved after 6 months of combination therapy.
    • Relation:
      https://figshare.com/articles/journal_contribution/Supplementary_figure_S1_from_Low-dose_Paclitaxel_with_Pembrolizumab_Enhances_Clinical_and_Immunologic_Responses_in_Platinum-refractory_Urothelial_Carcinoma/25288985
    • الرقم المعرف:
      10.1158/2767-9764.25288985.v1
    • Rights:
      CC BY
    • الرقم المعرف:
      edsbas.D593096D